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WS6.1 A cross-sectional evaluation of factors inﬂuencing adherence
in children with cystic ﬁbrosis
N.A. Goodfellow1, A. Reid2, M.D. Shields3, A.F. Hawwa1, J.C. McElnay1.
1Queen’s University, School of Pharmacy, Belfast, United Kingdom; 2Royal Belfast
Hospital for Sick Children, Northern Ireland Regional Paediatric Cystic Fibrosis
Centre, Belfast, United Kingdom; 3Queen’s University, School of Medicine,
Dentistry and Biomedical Sciences, Belfast, United Kingdom
Objectives: To evaluate adherence to enzyme supplements, vitamins and chest
physiotherapy in children using a multi-method approach and to examine factors
inﬂuencing adherence.
Methods: Adherence to therapy was measured using scores from the self-reported
parent and child (11 years) Medication Adherence Report Scale (MARS), pre-
scription reﬁll history from community pharmacy and General Practitioner prescrip-
tion issue history. Adherence was determined when the participant scored 80%
in all applicable measurement methods. Furthermore, beliefs about medication
were assessed in children 11 years and parents using a modiﬁed Beliefs about
Medicine Questionnaire (BMQ), quality of life was assessed using the Cystic
Fibrosis Questionnaire-Revised and parental depressive symptoms were examined
using the Center for Epidemiologic Studies Depression Scale.
Results: 100 children with cystic ﬁbrosis (birth to 18 years) and their parents were
recruited from the paediatric cystic ﬁbrosis centre at the Royal Belfast Hospital
for Sick Children between November 2010 and September 2011. Adherence varied
between treatment and adherence measure (Table 1).
Conclusion: Logistic regression analysis indicated that increased child age and low
parental necessity beliefs were signiﬁcant, independent drivers of non-adherence to
enzyme supplements and chest physiotherapy.
Table 1. Participants indicating adherence
Enzyme supplements Vitamins Chest physiotherapy
MARS parent 92% n= 76 90% n= 93 61% n= 90
MARS child (11 years) 55% n= 33 81% n= 43 51% n= 43
Pharmacy records 40% n= 80 47% n= 96 N/A
General Practitioner records 44% n= 80 54% n= 96 N/A
WS6.2 The impact of transition to adult services on weight and BMI
for patients with cystic ﬁbrosis
C.A. Cousins1, C.S. Haworth2, R.A. Floto2,3, H.C. Barker2, N.T. Shaﬁ2,
C.M. Johnson2, H.M. Watson1. 1Papworth Hospital, Nutrition and Dietetics,
Cambridge, United Kingdom; 2Papworth Hospital, Cambridge Centre for Lung
Infection, Cambridge, United Kingdom; 3Wellcome Trust, Cambridge, United
Kingdom
The importance of good nutritional care in Cystic Fibrosis is well recognised with
malnutrition shown to be an independent risk factor for poor survival (Steinkamp,
2002). Body Mass Index (BMI) is routinely used as a measure of nutritional status
in CF patients (CF Trust, 2002) although it is inﬂuenced by height changes in the
adolescent population (Sinaasappel, 2002). The median BMI for UK Adult centres
is 21.3 kg/m2, while the average BMI for Papworth is 21.6 kg/m2 (CF Trust, 2011).
Patients transition to the Papworth Hospital Adult CF Centre from 8 paediatric units
covering a wide geographical area, with differing approaches to dietetic care. We
therefore sought to examine the impact of transition from paediatric to adult care on
BMI and weight. We examined the change in weight and BMI for the ﬁrst 2 years
following transition to our adult clinic. Annual review data was collected from Port
CF (CF Trust, 2007) for all new patients seen at Papworth between January 2007
and November 2012. Analysis was limited to 54 patients who had complete data
sets for 2 years. Weight and BMI at transition were compared to measurements
following 1 (PT1) and 2 (PT2) years at our service using paired Student T test.
Results
Weight (SD) BMI (SD)
Baseline 56.7 kg (12.4) 21.1 kg/m2 (3.64)
PT 1 year 57.8 kg (4.90) p = 0.10 21.4 kg/m2 (1.67) p = 0.16
PT 2 year 58.8 kg (5.19) p= 0.004 21.7 kg/m2 (1.75) p= 0.01
Our results suggest that both weight and BMI are signiﬁcantly improved following
2 years at our Adult CF Centre, reﬂecting the success of our nutritional support
programme, and indicate that the CF registry BMI data may not fully capture
important nutritional changes post transition.
WS6.3 Airway clearance and physical activity − Results from a UK
survey
K.V. Ferguson1, K. Old2. 1Kings College Hospital, Physiotherapy Department,
London, United Kingdom; 2Cystic Fibrosis Trust, London, United Kingdom
Combined data from posters 209, 210 and 211 will be presented.
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Objectives: By now, there is an 8 year experience of benchmarking (BM) ‘learning
from best practice’ in CF care (CFC) in Germany. CFC has been evaluated and
optimized using this method. Individual aspects have been checked to ﬁnd out
potential for quality improvement (QI).
Methods: In two annual meetings moderated by an external expert, information has
been exchanged between participating CF centres about consensus quality indicators
(e.g. BMI and BMI percentiles, FEV1 changes and microbiological as well as
quality of life data), based on the German CF registry. Following best practice,
patient-oriented steps have been derived to create speciﬁc tasks for participants and
to feed a consistent systematic plan-do-check-act-cycle. Since 2004, the number
of participating centres has been increasing from 12 to 31, the number of patients
included in BM has been rising from 1200 to 3200. The proportion of patients
(6−18 years of age) with FEV1 over 100% has been slightly increasing from 43%
to 46%. The rate of annual visits was rising from 3 to 4. In addition to procedural
improvements, supporting materials, checklists and algorithms (what to do when
there is a drop of FEV1) have been created and provided to all German CF centres.
Conclusion: Using a systematic BM approach, potential was identiﬁed for QI, and
operational procedures were improved accordingly. A continuous quality awareness
was established in the BM centres particularly for interdisciplinary CF teams. More
positive effects on quality markers in CF patients are to be expected in the long
run. BM in CFC is an appropriate model tool, possibly also suitable for patients
with other chronic diseases.
